Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated significant weight loss results in large-scale clinical trials. When taken as directed, patients typically lose between 10 and 15 percent of their starting body weight within 16 months. Individual outcomes vary based on lifestyle, genetics, dosing consistency, and metabolic factors.
Clinical Trial Results for Semaglutide Weight Loss
The STEP trials (Semaglutide Treatment Effect in People with obesity) followed over 4,500 participants across multiple studies. In the primary STEP 3 trial, patients receiving semaglutide 2.4 mg weekly lost an average of 10.9% of their body weight, compared to 2.4% in the placebo group. These results were sustained over the full study period, demonstrating that weight loss was not temporary or dependent on initial motivation alone.
Subset analysis revealed that weight loss magnitude correlates with adherence and dosage escalation. Participants who reached and maintained the maximum dose of 2.4 mg weekly consistently achieved the largest reductions. Some patients in the trials lost more than 20% of their starting weight, though this outcome represents approximately 35% of the active treatment group rather than the average.
How Individual Weight Loss Varies with Semaglutide
Semaglutide reduces appetite by activating GLP-1 receptors in the brain's satiety center and slowing stomach emptying. This mechanism helps patients feel fuller longer and consume fewer calories naturally, but the degree of response differs between individuals. Factors like baseline metabolic rate, insulin resistance, diet quality, physical activity, sleep patterns, and stress levels all influence how much weight a person loses.
Genetic variation also plays a measurable role in treatment response. The PlexusDx Precision Peptide Genetic Test analyzes variants in key appetite and metabolism genes—including GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313—to predict how your body may respond to semaglutide therapy. Understanding your genetic predisposition helps optimize dosing and realistic goal-setting before starting treatment.
Timeline for Semaglutide Weight Loss Results
Most patients begin noticing appetite suppression and initial weight changes within 2 to 4 weeks of starting semaglutide at the lowest dose (0.25 mg weekly). Meaningful weight loss—typically 5 to 10 pounds—becomes apparent by weeks 8 to 12 as the dose is gradually increased. The escalation phase, called titration, usually spans 16 weeks, moving from 0.25 mg to 0.5 mg to 1.0 mg to 1.7 mg to the target 2.4 mg weekly.
Peak weight loss generally occurs between months 4 and 6 of consistent treatment. After reaching maintenance dose, weight loss often plateaus or slows because your body adapts to the medication and caloric deficit. Continued adherence prevents weight regain, which commonly occurs after discontinuation—making long-term consistency more important than short-term intensity.
Semaglutide Access Through PlexusDx
PlexusDx offers compounded semaglutide injections prepared by licensed 503A compounding pharmacies, starting at $149 per month across all three subscription tiers. Your dose may need to go up. Your price won't—PlexusDx maintains flat monthly pricing regardless of dose escalation, ensuring transparency and affordability as treatment progresses. No insurance is required, and all compounded medications are HSA and FSA eligible.
Semaglutide injections from PlexusDx are shipped directly to your home and can be stored in a standard refrigerator. The service covers all 50 states, and patients can request the optional Precision Peptide Genetic Test after one month of treatment for an additional $99. This test identifies your genetic profile across 14 metabolic pathways and 49 peptides, helping your provider personalize your exact dosing schedule for maximum efficacy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the realistic amount of weight I should expect to lose on semaglutide?
Most people lose 10-15% of their body weight over 4-6 months with consistent semaglutide use at the full 2.4 mg dose. If you weigh 200 pounds, expect to lose approximately 20-30 pounds on average. Some patients achieve 20%+ losses, while others see more modest results depending on genetics, diet, exercise, and individual metabolism.
How does semaglutide cause weight loss?
Semaglutide activates GLP-1 receptors in your brain and gut, reducing hunger signals and increasing feelings of fullness. It also slows stomach emptying, so food stays in your stomach longer. Together, these effects reduce overall calorie intake without requiring willpower-based restriction, making weight loss more sustainable.
Can I get semaglutide without insurance?
Yes. PlexusDx delivers compounded semaglutide injections to all 50 states without requiring insurance. Treatment starts at $149 per month, and HSA/FSA funds can be applied. There is no membership fee, and pricing remains flat regardless of your dose level.
Is compounded semaglutide as effective as brand-name Ozempic?
Compounded semaglutide from licensed 503A pharmacies contains the same active pharmaceutical ingredient as brand-name products and functions identically in your body. PlexusDx partners exclusively with licensed 503A compounding pharmacies to ensure quality and safety. Effectiveness depends on dosing, adherence, and individual response, not manufacturing source.
How does the PlexusDx Precision Peptide Genetic Test help with semaglutide results?
The test analyzes your genetic variants in GLP1R, GIPR, MC4R, FTO, and 10 other metabolic pathways to predict your likely response to semaglutide and identify optimal dosing. Patients with certain genetic profiles may benefit from faster dose escalation or combination therapy. For $99 after your first month, the test personalizes your treatment plan based on your peptide genetics.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Effectively Discuss Ozempic for Weight Loss with Your Healthcare Provider
How Quickly Do You Feel Side Effects from Wegovy?